Tirzepatide Cost: What You Actually Pay

Tirzepatide cost depends far more on which route you take than on the molecule. The brand-name pen carries a list price around $1,086 a month. The manufacturer's own self-pay vial program runs $299 to $449 a month depending on dose. Compounded tirzepatide through a telehealth prescriber is generally lower still. Same active ingredient, three very different bills.

The three tirzepatide cost routes

List price. The brand-name product's published monthly list price sits near $1,086 for the pen. This is the sticker number that generates headlines. It is what an uninsured person is quoted at a retail pharmacy with no program applied, and very few people actually pay it.

Manufacturer self-pay. The maker sells single-dose vials directly at tiered self-pay prices: roughly $299 a month at 2.5 mg, $399 at 5 mg, and $449 for doses from 7.5 mg through 15 mg. The vials require drawing the dose with a syringe rather than using a pen, and the higher-dose pricing depends on refilling within a set window.

Compounded. A compounded formulation prepared by a licensed pharmacy on a prescription. Through Promise, tirzepatide is $270 a month on a monthly plan; a single month on its own is $300, and a quarterly plan is $720.

Why insurance so often does not help

Coverage for weight management is the sticking point. Many plans cover tirzepatide readily for type 2 diabetes and exclude it for obesity, which is why two people on identical medication can face completely different bills. Where coverage exists it frequently comes with prior authorization, documented BMI thresholds, or a requirement to have tried other approaches first.

Manufacturer copay assistance can reduce cost substantially for people with commercial insurance that covers the drug, and does nothing for people whose plan excludes it. Government-insured patients are typically ineligible for those programs entirely. This is the structural reason the self-pay and compounded routes exist at all.

What compounded means here, precisely

Through Promise, tirzepatide is dispensed as a compounded medication, which is different from an FDA-approved product: the formulation offered here — tirzepatide with vitamin B12 — is not FDA-approved. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality.

That sentence is doing real work, so it is worth unpacking rather than skimming. A compounded medication is prepared by a licensed pharmacy for an individual patient on a prescription. It is a legitimate, regulated activity with its own oversight framework — but the specific preparation has not been through the review the branded product went through, and it is not the branded product.

What you are buying at the lower price is the molecule prepared by a licensed pharmacy, not a cheaper version of the brand. Anyone implying those are the same thing is selling you something.

What is included in the price

A quoted price is only comparable if you know what sits behind it. At Promise the monthly figure covers the online medical evaluation by a licensed provider, the prescription itself if that provider determines tirzepatide is appropriate for you, compounding and dispensing by a licensed U.S. pharmacy, temperature-safe shipping, and follow-up check-ins.

It is worth checking that list against anything you compare it to. A vial price with a separate consultation fee, a shipping charge and a refill fee attached is not the number it first appeared to be.

The comparison worth making

The genuinely useful comparison is not between two prices for tirzepatide. It is between a clinical service and an unverified vial.

Tirzepatide offered without a prescription is not manufactured to dispensing standards, has no clinician attached, and provides no accountability if the contents are wrong. Independent testing of consumer peptide products has repeatedly turned up incorrect quantities, degraded material and contaminants. The saving is real and so is what you give up for it.

The prescription route costs more than that and less than the brand. What the difference buys is a licensed provider who reviews your history and can decline, a licensed pharmacy whose output is documented, and somebody to call when something feels wrong.

Cost is not the only variable

Dose affects price on the manufacturer's tiers but not on Promise's flat monthly plan, which matters if you expect to escalate — see tirzepatide dosage and the titration ladder for how that progression normally works.

Tolerability affects cost too, in a way people rarely price in. Discontinuation for adverse events rose with dose to about 10% at 15 mg in pooled trial data (Mishra et al., J Endocr Soc 2023); a medication you stop taking in month two is expensive at any price. It cuts the other way as well — average weight reduction in SURMOUNT-1 was 15.0% at 5 mg against 20.9% at 15 mg (Jastreboff et al., NEJM 2022), so on the manufacturer's dose-tiered pricing the cheapest rung is not the one that does the least. Tirzepatide side effects covers what to expect, and tirzepatide versus semaglutide compares the two most common starting points, which differ in price as well as in profile.

Before you commit

Check whether your plan covers weight management specifically, not just whether it covers the drug. Ask any provider what the quoted price includes and what is billed separately. And be clear about which product you are being offered — brand, manufacturer self-pay vial, or compounded — because those are three different things sold at three different prices.

At Promise, a licensed provider reviews every request and prescribes only when tirzepatide is appropriate. Not everyone qualifies, and nobody is charged for a prescription that is not written.